Use of dopamine D2/D3 receptor agonists to treat fibromyalgia

Details for Australian Patent Application No. 2001271910 (hide)

International Classifications

Event Publications

4 December 2003 Assignment before Grant

Holman, Andrew The application has been assigned to CNS-Rheumatology, Inc.

28 July 2005 Application Accepted

Published as AU-B-2001271910

24 November 2005 Standard Patent Sealed

21 June 2007 Assignment Registered

CNS-Rheumatology, Inc. The patent has been assigned to InMedix, LLC.

23 August 2007 Assignment Registered

InMedix, LLC The patent has been assigned to Boehringer Ingelheim International GMBH

28 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.